Here at the Feinstein Institute, our scientists are dedicated to the most vital areas of cancer research – clinical trials, basic research and translational research – in order to better understand cancer, and to find new paths for shaping and delivering the best, most effective cancer treatments.
Oncology is the study of cancer. At The Feinstein Institute, cancer prevention is of utmost interest in our research laboratories. The long term goal of our research is to understand how primary cancer cells turn into aggressive metastatic cells. This understanding will blaze the path to discoveries that lead to the development of therapeutic strategies for preventing tumor spreading.
The Feinstein Institute recently established the Brain Tumor Biotech Center in an effort to bring together scientists, clinicians and biotech companies to accelerate the delivery of novel drugs for treating brain cancer.
Hematology is the study of blood and its disorders. Hematologists look specifically at blood components such as blood count, and blood and bone marrow cells.
At the Feinstein Institute, clinical trials are developed in order to measure the effectiveness of new treatments, as well as trials that revolve around prevention for such diseases as anemias, thalassemias, bleeding / clotting disorders, hemochromatosis, polycythemia vera, thrombocythemia, leukemias and lymphomas. Our research efforts center around evaluating the safety, effectiveness, and potential toxicities of newly developed treatments. From laboratory to bedside, our clinical trials play a large part in improving and advancing patient care.